Kirk Look - 01 Jun 2026 Form 4 Insider Report for ONCOLYTICS BIOTECH INC (ONCY)

Reporting relationship: Chief Financial Officer
Issuer ticker: ONCY
Reported as of: 01 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Jun 2026, 16:30:35 UTC
Prior SEC filing: 13 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Kirk Look

Key filing fact

Kirk Look filed Form 4 for ONCOLYTICS BIOTECH INC (ONCY) on 03 Jun 2026.

Key facts

This page summarizes Kirk Look's Form 4 filing for ONCOLYTICS BIOTECH INC (ONCY).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 03 Jun 2026, 16:30.

Change

Previous filing in this sequence was filed on 13 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002103582 Primary reporting owner

Look Kirk

Relationship: Chief Financial Officer
Address: C/O ONCOLYTICS BIOTECH INC., 4350 EXECUTIVE DRIVE, SUITE 325, SAN DIEGO
Signature: /s/ Kirk Look
Signature date: 03 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ONCY transaction Derivative

Stock Option

Award

Transaction value
Shares: +260,000
Change %
Price: $0.000000^*
Shares after: 260,000
Date: 01 Jun 2026
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 260,000
Exercise price: $1.06
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Capital Market on the date of grant, June 1, 2026.

Footnote F2

The stock option vests in three equal annual installments with the first tranche vesting on June 1, 2027, subject to the Reporting Person's continued service or employment, as applicable, on each such vesting date.